Giannangeli Giancarlo MD is categorized under Internal Medicine Doctors in Wykagyl, NY and active since 1990.
Giannangeli Giancarlo MD was established in 1990, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Giancarlo Giannangeli at the company’s single location by writing to 19 Verdun Avenue, Wykagyl, New York NY 10804 or by phoning (914) 636-3232. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Giannangeli Giancarlo MD |
| Contact Person: | Giancarlo Giannangeli |
| Address: | 19 Verdun Avenue, Wykagyl, New York 10804 |
| Phone Number: | (914) 636-3232 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 1990 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Internal Medicine Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Giannangeli Giancarlo MD was started in 1990 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Giancarlo Giannangeli for inquiries that concern Giannangeli Giancarlo MD by calling the company number (914) 636-3232, as your correspondence is most welcome. Additionally, the physical location of the single location of Giannangeli Giancarlo MD can be found at the coordinates 40.951851,-73.791873 as well as the street address 19 Verdun Avenue in Wykagyl, New York 10804.
For its online presence, you may visit Giannangeli Giancarlo MD’s website at and engage with its social media outlets through on Twitter and on Facebook.